Dynamics in business models: An empirical analysis of medical biotechnology firms in the Netherlands

被引:49
|
作者
Willemstein, L. [1 ]
van der Valk, T. [1 ]
Meeus, M. T. H. [1 ]
机构
[1] Univ Utrecht, Dept Innovat & Environm Sci, NL-3508 TC Utrecht, Netherlands
关键词
biotechnology firms; business model dynamics; value-added sequence;
D O I
10.1016/j.technovation.2006.08.005
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
In this paper, business models of Dutch dedicated biotechnology firms (DBFs) that are active in the field of medical biotechnology are examined. The focus is on the dynamics in business models within the. Dutch population and the mechanisms that generate these dynamics. Furthermore, we propose a value-added sequence of the business model of a firm over time and examine if this sequence is found in the population of the Dutch DBFs. We focus on the business models at founding and the shifts that occurred in these business models afterwards. Therefore, data on a survey completed by 80 Dutch DBFs was used together with longitudinal data on shifts in business models of four case studies. We show that both the generation of new firms, due to shifts in the dominating business model at founding over time, and shifts in business models after founding contribute to the dynamics in business models within this population. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
  • [1] Business Models in the Spanish biotechnology firms
    March Chorda, Isidre
    Seoane Trigo, Ramon
    [J]. UNIVERSIA BUSINESS REVIEW, 2006, (12): : 22 - 35
  • [2] Services and the Business Models of Product Firms: An Empirical Analysis of the Software Industry
    Suarez, Fernando F.
    Cusumano, Michael A.
    Kahl, Steven J.
    [J]. MANAGEMENT SCIENCE, 2013, 59 (02) : 420 - 435
  • [3] Empirical analysis of innovation strategies of biotechnology firms in the US
    Chakrabarti, Alok K.
    Weisenfeld, Ursula
    [J]. Journal of Engineering and Technology Management - JET-M, 1991, 8 (3-4): : 243 - 260
  • [4] Commercialization strategies of young biotechnology firms: An empirical analysis of the US industry
    Kasch, Silja
    Dowling, Michael
    [J]. RESEARCH POLICY, 2008, 37 (10) : 1765 - 1777
  • [5] An Analysis of New Business Models for Internet Firms
    Zhao, Shuying
    Jia, Xiao
    [J]. INTERNATIONAL CONFERENCE ON ENGINEERING AND BUSINESS MANAGEMENT (EBM2011), VOLS 1-6, 2011, : 554 - 556
  • [6] Business models for the Blockchain: An empirical analysis
    Upadhyay, Nitin
    [J]. DIGITAL BUSINESS, 2024, 4 (02):
  • [7] Business models in Italian biotechnology industry: a quantitative analysis
    Bigliardi, B
    Nosella, A
    Verbano, C
    [J]. TECHNOVATION, 2005, 25 (11) : 1299 - 1306
  • [8] Exploring business models for managing uncertainty in healthcare, medical devices, and biotechnology industries
    Javanmardi, Ehsan
    Maresova, Petra
    Xie, Naiming
    Mierzwiak, Rafal
    [J]. HELIYON, 2024, 10 (04)
  • [9] Characteristics of the Italian biotechnology industry and new business models: the initial results of an empirical study
    Nosella, A
    Petroni, G
    Verbano, C
    [J]. TECHNOVATION, 2005, 25 (08) : 841 - 855
  • [10] Strategies and performance of Canadian biotechnology firms: An empirical investigation
    Woiceshyn, J
    Hartel, D
    [J]. TECHNOVATION, 1996, 16 (05) : 231 - 243